Genetics of Congenital Heart Disease: Past and Present

被引：0
作者：
Iolanda Muntean
Rodica Togănel
Theodora Benedek
机构：
[1] University of Medicine and Pharmacy Tîrgu Mureş,Institute of Cardiovascular Diseases and Transplantation, Clinic of Pediatric Cardiology
[2] University of Medicine and Pharmacy Tîrgu Mureş,Clinic of Cardiology
来源：
Biochemical Genetics | 2017年 / 55卷
关键词：
Congenital heart disease; Copy number variants; Single-nucleotide polymorphism; Next-generation sequencing; Micro RNA; Epigenetic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Congenital heart disease is the most common congenital anomaly, representing an important cause of infant morbidity and mortality. Congenital heart disease represents a group of heart anomalies that include septal defects, valve defects, and outflow tract anomalies. The exact genetic, epigenetic, or environmental basis of congenital heart disease remains poorly understood, although the exact mechanism is likely multifactorial. However, the development of new technologies including copy number variants, single-nucleotide polymorphism, next-generation sequencing are accelerating the detection of genetic causes of heart anomalies. Recent studies suggest a role of small non-coding RNAs, micro RNA, in congenital heart disease. The recently described epigenetic factors have also been found to contribute to cardiac morphogenesis. In this review, we present past and recent genetic discoveries in congenital heart disease.
引用
收藏
页码：105 / 123
页数：18
相关论文
共 717 条
[11]  
Reeves RH(2014)Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease J Am Coll Cardiol 64 2498-2506
[12]  
Sherman SL(2008)MicroRNAs control gene expression: importance for cardiac development and pathophysiology Ann N Y Acad Sci 1123 20-29
[13]  
Maslen CL(2004)Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development Mol Cell Biol 24 8467-8476
[14]  
Alagille D(2010)HDAC inhibitors–new generation of target specific treatment Mini Rev Med Chem 10 1263-1276
[15]  
Odievre M(2003)Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice Proc Natl Acad Sci USA 100 10794-10799
[16]  
Gautier M(2010)A restricted spectrum of NRAS mutations cause Noonan syndrome Nat Genet 42 27-29
[17]  
Dommergues JP(2009)The biology of chromatin remodeling complexes Ann Rev Biochem 78 273-304
[18]  
Andelfinger G(2010)Long-term outcomes of patients with cardiovascular abnormalities and William syndromes Am J Cardiol 105 874-878
[19]  
Aoki Y(2015)The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects Front Genet 25 223-186
[20]  
Niihori T(2001)Identification of connexin43 (alpha-1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE) Mutat Res 479 173-394
12345678910